These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9089710)
41. Two-step radio-immunotargeting of renal-cell carcinoma xenografts in nude mice with anti-renal-cell-carcinoma X anti-DTPA bispecific monoclonal antibodies. Kranenborg MH; Boerman OC; Oosterwijk-Wakka JC; de Weijert MC; Corstens FH; Oosterwijk E Int J Cancer; 1998 Jan; 75(1):74-80. PubMed ID: 9426693 [TBL] [Abstract][Full Text] [Related]
42. Preclinical evaluation of 111In-labeled B3 monoclonal antibody: biodistribution and imaging studies in nude mice bearing human epidermoid carcinoma xenografts. Camera L; Kinuya S; Pai LH; Garmestani K; Brechbiel MW; Gansow OA; Paik CH; Pastan I; Carrasquillo JA Cancer Res; 1993 Jun; 53(12):2834-9. PubMed ID: 8504427 [TBL] [Abstract][Full Text] [Related]
43. Targeting strategies for cancer radiotherapy. Buchsbaum DJ; Rogers BE; Khazaeli MB; Mayo MS; Milenic DE; Kashmiri SV; Anderson CJ; Chappell LL; Brechbiel MW; Curiel DT Clin Cancer Res; 1999 Oct; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342 [TBL] [Abstract][Full Text] [Related]
44. Localization of monoclonal antibody G250 and bispecific monoclonal antibody CD3/G250 in human renal-cell carcinoma xenografts: relative effects of size and affinity. van Dijk J; Zegveld ST; Fleuren GJ; Warnaar SO Int J Cancer; 1991 Jul; 48(5):738-43. PubMed ID: 1830033 [TBL] [Abstract][Full Text] [Related]
53. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies. Buchsbaum DJ; Brubaker PG; Hanna DE; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z Cancer Res; 1990 Feb; 50(3 Suppl):993s-999s. PubMed ID: 2297753 [TBL] [Abstract][Full Text] [Related]
54. Biodistribution of 111In- and 90Y-labeled DOTA and maleimidocysteineamido-DOTA conjugated to chimeric anticarcinoembryonic antigen antibody in xenograft-bearing nude mice: comparison of stable and chemically labile linker systems. Williams LE; Lewis MR; Bebb GG; Clarke KG; Odom-Maryon TL; Shively JE; Raubitschek AA Bioconjug Chem; 1998; 9(1):87-93. PubMed ID: 9460550 [TBL] [Abstract][Full Text] [Related]
55. PET-radioimmunodetection of integrins: imaging acute colitis using a ⁶⁴Cu-labeled anti-β₇ integrin antibody. Dearling JL; Packard AB Methods Mol Biol; 2012; 757():487-96. PubMed ID: 21909929 [TBL] [Abstract][Full Text] [Related]
56. Biologic evaluation of a novel 188Re-labeled porphyrin in mice tumor model. Sarma HD; Das T; Banerjee S; Venkatesh M; Vidyasagar PB; Mishra KP Cancer Biother Radiopharm; 2010 Feb; 25(1):47-54. PubMed ID: 20187796 [TBL] [Abstract][Full Text] [Related]
57. Radioimmunotherapy for pancreatic carcinoma using (131)I-labeled monoclonal antibody Nd2 in xenografted nude mice. Inui A; Chung YS; Sawada T; Kondo Y; Ho JJ; Kim YS; Sowa M Jpn J Cancer Res; 1996 Sep; 87(9):977-84. PubMed ID: 8878462 [TBL] [Abstract][Full Text] [Related]
58. Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates. Law CL; Gordon KA; Toki BE; Yamane AK; Hering MA; Cerveny CG; Petroziello JM; Ryan MC; Smith L; Simon R; Sauter G; Oflazoglu E; Doronina SO; Meyer DL; Francisco JA; Carter P; Senter PD; Copland JA; Wood CG; Wahl AF Cancer Res; 2006 Feb; 66(4):2328-37. PubMed ID: 16489038 [TBL] [Abstract][Full Text] [Related]
59. Using starburst dendrimers as linker molecules to radiolabel antibodies. Roberts JC; Adams YE; Tomalia D; Mercer-Smith JA; Lavallee DK Bioconjug Chem; 1990; 1(5):305-8. PubMed ID: 2098106 [TBL] [Abstract][Full Text] [Related]
60. Biodistribution of 18F- and 125I-labeled anti-Tac disulfide-stabilized Fv fragments in nude mice with interleukin 2 alpha receptor-positive tumor xenografts. Choi CW; Lang L; Lee JT; Webber KO; Yoo TM; Chang HK; Le N; Jagoda E; Paik CH; Pastan I Cancer Res; 1995 Nov; 55(22):5323-9. PubMed ID: 7585595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]